Physician profile
Eric J Miller
NPI 1619974789
$745.79
in general payments reported to CMS, 2019-2025
16 companies · $95.50 in 2025
The $95.50 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $150 · 2021: $156 · 2022: $196 · 2025: $95.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $95.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $95.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $145.98 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $138.54 | 2019-2025 | Belbuca |
| Degen Medical, INC. | $120.62 | 2022 | |
| Pfizer INC. | $52.04 | 2019-2020 | |
| Grt US Holding, INC. | $42.75 | 2021 | |
| Nevro Corp. | $35.13 | 2019-2020 | |
| Boston Scientific Corporation | $32.07 | 2019-2022 | |
| Si-Bone, INC. | $30.81 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $30.04 | 2025 | |
| Globus Medical, INC. | $28.88 | 2025 | Senza |
| Forte Bio-Pharma LLC | $20.27 | 2021 | |
| Baudax Bio INC. | $17.78 | 2021 | |
| Shionogi INC | $13.68 | 2019 | |
| Azurity Pharmaceuticals, INC. | $13.61 | 2025 | Horizant |
| Ibsa Pharma INC. | $11.92 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $11.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.